ornithine has been researched along with Diabetic Nephropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Chi, Q; Ding, G; Hu, J; Liang, W; Luo, Q; Yang, K; Zhang, Z; Zhu, Z | 1 |
| Cao, P; Cao, R; Cao, Y; Chi, C; Hong, M; Huang, B; Jiang, Y; Li, S | 1 |
| Devi, S; Kuriyan, R; Kurpad, AV; Limesh, M; Mukhopadhyay, A; Nongkhlaw, B; Pasanna, RM; Thomas, T | 1 |
| Awad, AS; Cooper, TK; Gao, T; Morris, SM; You, H | 1 |
| Carmines, PK; Foster, JM; Pollock, JS | 1 |
| Carlsson, PO; Friederich, M; Hansell, P; Liss, P; Palm, F; Teerlink, T | 1 |
6 other study(ies) available for ornithine and Diabetic Nephropathies
| Article | Year |
|---|---|
Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
Topics: Animals; Diabetes Mellitus; Diabetic Nephropathies; Glucose; Glycolysis; Mammals; Mice; Ornithine; Podocytes; TOR Serine-Threonine Kinases | 2022 |
Association of amino acids related to urea cycle with risk of diabetic nephropathy in two independent cross-sectional studies of Chinese adults.
Topics: Adult; Arginine; Citrulline; Cross-Sectional Studies; Diabetes Mellitus; Diabetic Nephropathies; Humans; Ornithine; Urea | 2022 |
Acyl ethanolamides in Diabetes and Diabetic Nephropathy: Novel targets from untargeted plasma metabolomic profiles of South Asian Indian men.
Topics: Adult; Amino Acids; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Imidazoles; India; Lactates; Male; Middle Aged; Ornithine; Socioeconomic Factors | 2019 |
Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
Topics: Albuminuria; Animals; Arginase; Biomarkers; Blood Urea Nitrogen; Boronic Acids; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Fibronectins; Infusions, Subcutaneous; Kidney; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Ornithine; Oxidative Stress; Streptozocin; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
PP2B-dependent NO production in the medullary thick ascending limb during diabetes.
Topics: Amidines; Animals; Benzylamines; Calcineurin; Calcineurin Inhibitors; Cell Survival; Cyclic N-Oxides; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Kidney Medulla; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Ornithine; Phosphorylation; Rats; Rats, Sprague-Dawley; Spin Labels; Up-Regulation | 2009 |
Reduced nitric oxide in diabetic kidneys due to increased hepatic arginine metabolism: implications for renomedullary oxygen availability.
Topics: alpha-Tocopherol; Animals; Antioxidants; Arginase; Arginine; Blood Pressure; Cationic Amino Acid Transporter 2; Cell Hypoxia; Citrulline; Diabetic Nephropathies; Glomerular Filtration Rate; Kidney Medulla; Liver; Male; Nitric Oxide; Ornithine; Oxidative Stress; Oxygen; Rats; Rats, Inbred WF; Regional Blood Flow | 2008 |